Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Predicting cancer evolution for patient benefit: Renal cell carcinoma paradigm

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer(2022)10.1016/j.bbcan.2022.188759Source: DataRank Database

Predicting cancer evolution for patient benefit: Renal cell carcinoma paradigm is a research paper published in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: hybridTopics (21)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Samra Turajlic ORCID,Husayn Ahmed Pallikonda ORCID

Live enrichment

PubMed:35835341

Cancer Research UK

Grant: 29911

Wellcome Trust

Grant: FC0010988

Cancer Research UK

Grant: 18176

Cancer Research UK

Grant: C50947/A18176

The Francis Crick Institute

Grant: 10988

Wellcome Trust

Grant: unidentified

unidentified

European Commission

Grant: 247439

Disposable Point-of-Care DNA kit for Mycobacterium tuberculosis

National Institutes of Health

Grant: 5U01CA247439-02

Deciphering Clonal Evolution in Hereditary Renal Cell Carcinomas

National Institute for Health Research (NIHR)

hybridLicense: cc-by

publisherhttps://www.sciencedirect.com/science/article/pii/S0304419X22000841/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0304419X22000841?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304419X22000841?httpAccept=text/plain

repositoryhttps://figshare.com/articles/journal_contribution/Predicting_cancer_evolution_for_patient_benefit_Renal_cell_carcinoma_paradigm_/20431110

repositoryhttps://doi.org/10.25418/crick.20431110.v1

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansCarcinoma, Renal CellKidney Neoplasms

Keywords

Patient ManagementClear Cell Renal Cell CarcinomaPatient BenefitCancer EvolutionCancer DynamicsSubclonal ReconstructionRepresentative SequencingSignalling & OncogenesGenome Integrity & RepairHumansTumour BiologyCarcinoma, Renal CellGenetics & GenomicsKidney NeoplasmsComputational & Systems Biology

Sustainable Development Goals

SDG 3: 3. Good health